| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099213 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering |
| 07/25/2002 | US20020099210 Able to inhibit binding of integrins to their ligands and are of use in the prophylaxis and therapy of immune or inflammatory disorders |
| 07/25/2002 | US20020099209 Dihydrostilbene alkanoic acid derivatives |
| 07/25/2002 | US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 07/25/2002 | US20020099207 Has activity as an antagonist to neurokinin 1 receptors; for therapy of benign prostatic hyperplasia (BPH) |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/25/2002 | US20020099080 Indole derivatives useful A.O. for the treatment of osteoporosis |
| 07/25/2002 | US20020099079 Treating psoriasis, ulcers, gastroesophageal reflux and conditions caused by gastric hypersecretion including Zollinger-Ellison Syndrome, by administering hydroxylansoprazole or salt |
| 07/25/2002 | US20020099078 Aryloxy piperidinyl indoles for treating depression |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099053 Solvates of pymetrozine |
| 07/25/2002 | US20020099035 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 07/25/2002 | US20020099030 Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties |
| 07/25/2002 | US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 07/25/2002 | DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2435141A1 Compositions for prevention or treatment of hepatopathy |
| 07/25/2002 | CA2432870A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | CA2432776A1 Isoindolyl and isoquinolinyl aroyl pyrrole compounds |
| 07/24/2002 | EP1225170A2 Cycloheptene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/24/2002 | EP1225169A1 Radiation-activated cytotoxin therapy |
| 07/24/2002 | EP1224186A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224182A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 07/24/2002 | EP1224181A1 Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224179A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224169A2 Production of 5-substituted indolinones and use thereof as medicaments |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223944A1 Thrombopoietin mimetics |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223924A2 Use of csaids in rhinovirus infection |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0936910B1 Intracoronary stents containing quinazolinone derivatives |
| 07/24/2002 | EP0900793B1 Cycloalkylaminomethylpyrrolidine derivatives |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | EP0734383B1 Cyclic amide derivatives as neurokinin a antagonists |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
| 07/24/2002 | CN1088063C Sulfmidyl (thio) carbonyl-1,2,4-triazolineone deriv. and preparation method and application as weed killer |
| 07/24/2002 | CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands |
| 07/23/2002 | US6423846 High-yield method for preparing lansoprazole |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423728 Heterocyclic thioamide derivatives |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423724 Prevention, therapy disease |
| 07/23/2002 | US6423723 Oral bioavailability |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423718 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
| 07/23/2002 | US6423716 Nitrogenous heterocyclic compounds |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423707 Nitroimidazole ester analogues and therapeutic applications |
| 07/23/2002 | US6423704 Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 07/23/2002 | US6423519 Contacting fungal cell with compound which inhibits prenyltransferase activity of cell, including permease tag which facilitates permease-mediated transport of compound into cell, inhibiting growth thereof |
| 07/23/2002 | CA2102180C Novel immunosuppressive pyrrolidine/piperidine/azepane-2-carboxylic acid derivatives |
| 07/18/2002 | WO2002055609A2 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055516A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
| 07/18/2002 | WO2002055515A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055500A1 Coupler/developer and coupler/coupler hybrid dyes and coupler/developer and coupler/coupler hybrid dye intermediates |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055495A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055486A2 Triazene compounds and use thereof |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
| 07/18/2002 | WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2002000623A3 Aryl fused substituted 4-oxy-pyridines |
| 07/18/2002 | WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001056974A3 Inha inhibitors and their use as antibacterials |
| 07/18/2002 | US20020095044 Substituted isoindolinone derivatives |
| 07/18/2002 | US20020094994 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 07/18/2002 | US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094976 Polymer stabilizers; oxygen, heat, radiation resistances; discoloration inhibition; coatings; fibers; tapes; films; papermaking; HALS; fireproofing; oxidation of a 1-allyl-substituted sterically hindered amine |
| 07/18/2002 | US20020094936 Fungicidal activity |
| 07/18/2002 | DE10102404A1 Triazenverbindungen sowie deren Verwendung Triazene compounds and their use |
| 07/18/2002 | CA2434274A1 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | CA2434205A1 1,1-disubstituted cyclic inhibitors of matrix metalloprotease and tnf-.alpha. |